PATENT CLAIM ANALYSIS

Application Number: 15869929
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-12
Patent Classification: ["424", "133100"]

Abstract:
The present invention relates to the treatment or prevention of tinnitus. More precisely, the present invention relates to a compound modulating chloride co-transporter NKCC1 (chloride co-transporter modulator) for use in the treatment of tinnitus. In addition, the present invention concerns pharmaceutical compositions comprising such an NKCC1 chloride co-transporter modulator as an active agent, a method for the treatment or prevention of tinnitus by administering such a chloride co-transporter modulator, an a screening method for the identification and characterization of compounds capable of modulating chloride co-transporter NKCC1.

Claim (Index 25):
A screening method for the identification and characterization of compounds capable of modulating one or more chloride transporters comprising (a) providing cells stably expressing the one or more chloride transporters, (b) adding a test compound to the cells, (c) adding a transporter cation and (d) measuring the cation transport across the cell membrane.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 86.0
- Lexical Diversity: 2.02128
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14443154', '14087244', '13380921', '14894621', '11251724']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.740267987094367
- 35 USC 102 Novelty (BERT): 0.5446964887859401
- Combined Prediction Score: 0.7207108372635243
- Mean Citation Score: 308.9860060000001
- Max Citation Score: 461.20798
- Similarity Product: 258.5876307695389

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test